HER2 Antibodies Market, Global Outlook and Forecast 2022-2028

March 2022 | 68 pages | ID: H4008FCF1354EN
Market Monitor Global

Abstracts

The demand of HER2 Antibodies is increasing, and primarily gaining from growing awareness regarding the prevalence of HER2 positive breast cancer.

This report contains market size and forecasts of HER2 Antibodies in Global, including the following market information:

Global HER2 Antibodies Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global HER2 Antibodies market was valued at 8527 million in 2021 and is projected to reach US$ 11830 million by 2028, at a CAGR of 4.8% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Trastuzumab Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of HER2 Antibodies include Novartis, Pfizer, Roche, Abnova, InvivoGen, Celltrion, Biocon and Novus Biologicals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the HER2 Antibodies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global HER2 Antibodies Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global HER2 Antibodies Market Segment Percentages, by Type, 2021 (%)

• Trastuzumab
• Lapatinib
• Ado-trastuzumab emtansine
• Pertuzumab
• Everolimus

Global HER2 Antibodies Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global HER2 Antibodies Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• E-commerce

Global HER2 Antibodies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global HER2 Antibodies Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies HER2 Antibodies revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies HER2 Antibodies revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis
• Pfizer
• Roche
• Abnova
• InvivoGen
• Celltrion
• Biocon
• Novus Biologicals

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 HER2 Antibodies Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global HER2 Antibodies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HER2 ANTIBODIES OVERALL MARKET SIZE

2.1 Global HER2 Antibodies Market Size: 2021 VS 2028
2.2 Global HER2 Antibodies Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top HER2 Antibodies Players in Global Market
3.2 Top Global HER2 Antibodies Companies Ranked by Revenue
3.3 Global HER2 Antibodies Revenue by Companies
3.4 Top 3 and Top 5 HER2 Antibodies Companies in Global Market, by Revenue in 2021
3.5 Global Companies HER2 Antibodies Product Type
3.6 Tier 1, Tier 2 and Tier 3 HER2 Antibodies Players in Global Market
  3.6.1 List of Global Tier 1 HER2 Antibodies Companies
  3.6.2 List of Global Tier 2 and Tier 3 HER2 Antibodies Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global HER2 Antibodies Market Size Markets, 2021 & 2028
  4.1.2 Trastuzumab
  4.1.3 Lapatinib
  4.1.4 Ado-trastuzumab emtansine
  4.1.5 Pertuzumab
  4.1.6 Everolimus
4.2 By Type - Global HER2 Antibodies Revenue & Forecasts
  4.2.1 By Type - Global HER2 Antibodies Revenue, 2017-2022
  4.2.2 By Type - Global HER2 Antibodies Revenue, 2023-2028
  4.2.3 By Type - Global HER2 Antibodies Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global HER2 Antibodies Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 E-commerce
5.2 By Application - Global HER2 Antibodies Revenue & Forecasts
  5.2.1 By Application - Global HER2 Antibodies Revenue, 2017-2022
  5.2.2 By Application - Global HER2 Antibodies Revenue, 2023-2028
  5.2.3 By Application - Global HER2 Antibodies Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global HER2 Antibodies Market Size, 2021 & 2028
6.2 By Region - Global HER2 Antibodies Revenue & Forecasts
  6.2.1 By Region - Global HER2 Antibodies Revenue, 2017-2022
  6.2.2 By Region - Global HER2 Antibodies Revenue, 2023-2028
  6.2.3 By Region - Global HER2 Antibodies Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America HER2 Antibodies Revenue, 2017-2028
  6.3.2 US HER2 Antibodies Market Size, 2017-2028
  6.3.3 Canada HER2 Antibodies Market Size, 2017-2028
  6.3.4 Mexico HER2 Antibodies Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe HER2 Antibodies Revenue, 2017-2028
  6.4.2 Germany HER2 Antibodies Market Size, 2017-2028
  6.4.3 France HER2 Antibodies Market Size, 2017-2028
  6.4.4 U.K. HER2 Antibodies Market Size, 2017-2028
  6.4.5 Italy HER2 Antibodies Market Size, 2017-2028
  6.4.6 Russia HER2 Antibodies Market Size, 2017-2028
  6.4.7 Nordic Countries HER2 Antibodies Market Size, 2017-2028
  6.4.8 Benelux HER2 Antibodies Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia HER2 Antibodies Revenue, 2017-2028
  6.5.2 China HER2 Antibodies Market Size, 2017-2028
  6.5.3 Japan HER2 Antibodies Market Size, 2017-2028
  6.5.4 South Korea HER2 Antibodies Market Size, 2017-2028
  6.5.5 Southeast Asia HER2 Antibodies Market Size, 2017-2028
  6.5.6 India HER2 Antibodies Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America HER2 Antibodies Revenue, 2017-2028
  6.6.2 Brazil HER2 Antibodies Market Size, 2017-2028
  6.6.3 Argentina HER2 Antibodies Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa HER2 Antibodies Revenue, 2017-2028
  6.7.2 Turkey HER2 Antibodies Market Size, 2017-2028
  6.7.3 Israel HER2 Antibodies Market Size, 2017-2028
  6.7.4 Saudi Arabia HER2 Antibodies Market Size, 2017-2028
  6.7.5 UAE HER2 Antibodies Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Novartis
  7.1.1 Novartis Corporate Summary
  7.1.2 Novartis Business Overview
  7.1.3 Novartis HER2 Antibodies Major Product Offerings
  7.1.4 Novartis HER2 Antibodies Revenue in Global Market (2017-2022)
  7.1.5 Novartis Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer HER2 Antibodies Major Product Offerings
  7.2.4 Pfizer HER2 Antibodies Revenue in Global Market (2017-2022)
  7.2.5 Pfizer Key News
7.3 Roche
  7.3.1 Roche Corporate Summary
  7.3.2 Roche Business Overview
  7.3.3 Roche HER2 Antibodies Major Product Offerings
  7.3.4 Roche HER2 Antibodies Revenue in Global Market (2017-2022)
  7.3.5 Roche Key News
7.4 Abnova
  7.4.1 Abnova Corporate Summary
  7.4.2 Abnova Business Overview
  7.4.3 Abnova HER2 Antibodies Major Product Offerings
  7.4.4 Abnova HER2 Antibodies Revenue in Global Market (2017-2022)
  7.4.5 Abnova Key News
7.5 InvivoGen
  7.5.1 InvivoGen Corporate Summary
  7.5.2 InvivoGen Business Overview
  7.5.3 InvivoGen HER2 Antibodies Major Product Offerings
  7.5.4 InvivoGen HER2 Antibodies Revenue in Global Market (2017-2022)
  7.5.5 InvivoGen Key News
7.6 Celltrion
  7.6.1 Celltrion Corporate Summary
  7.6.2 Celltrion Business Overview
  7.6.3 Celltrion HER2 Antibodies Major Product Offerings
  7.6.4 Celltrion HER2 Antibodies Revenue in Global Market (2017-2022)
  7.6.5 Celltrion Key News
7.7 Biocon
  7.7.1 Biocon Corporate Summary
  7.7.2 Biocon Business Overview
  7.7.3 Biocon HER2 Antibodies Major Product Offerings
  7.7.4 Biocon HER2 Antibodies Revenue in Global Market (2017-2022)
  7.7.5 Biocon Key News
7.8 Novus Biologicals
  7.8.1 Novus Biologicals Corporate Summary
  7.8.2 Novus Biologicals Business Overview
  7.8.3 Novus Biologicals HER2 Antibodies Major Product Offerings
  7.8.4 Novus Biologicals HER2 Antibodies Revenue in Global Market (2017-2022)
  7.8.5 Novus Biologicals Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. HER2 Antibodies Market Opportunities & Trends in Global Market
Table 2. HER2 Antibodies Market Drivers in Global Market
Table 3. HER2 Antibodies Market Restraints in Global Market
Table 4. Key Players of HER2 Antibodies in Global Market
Table 5. Top HER2 Antibodies Players in Global Market, Ranking by Revenue (2021)
Table 6. Global HER2 Antibodies Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global HER2 Antibodies Revenue Share by Companies, 2017-2022
Table 8. Global Companies HER2 Antibodies Product Type
Table 9. List of Global Tier 1 HER2 Antibodies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 HER2 Antibodies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global HER2 Antibodies Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - HER2 Antibodies Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - HER2 Antibodies Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global HER2 Antibodies Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - HER2 Antibodies Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - HER2 Antibodies Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global HER2 Antibodies Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global HER2 Antibodies Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global HER2 Antibodies Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America HER2 Antibodies Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America HER2 Antibodies Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe HER2 Antibodies Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe HER2 Antibodies Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia HER2 Antibodies Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia HER2 Antibodies Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America HER2 Antibodies Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America HER2 Antibodies Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa HER2 Antibodies Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa HER2 Antibodies Revenue, (US$, Mn), 2023-2028
Table 30. Novartis Corporate Summary
Table 31. Novartis HER2 Antibodies Product Offerings
Table 32. Novartis HER2 Antibodies Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer HER2 Antibodies Product Offerings
Table 35. Pfizer HER2 Antibodies Revenue (US$, Mn), (2017-2022)
Table 36. Roche Corporate Summary
Table 37. Roche HER2 Antibodies Product Offerings
Table 38. Roche HER2 Antibodies Revenue (US$, Mn), (2017-2022)
Table 39. Abnova Corporate Summary
Table 40. Abnova HER2 Antibodies Product Offerings
Table 41. Abnova HER2 Antibodies Revenue (US$, Mn), (2017-2022)
Table 42. InvivoGen Corporate Summary
Table 43. InvivoGen HER2 Antibodies Product Offerings
Table 44. InvivoGen HER2 Antibodies Revenue (US$, Mn), (2017-2022)
Table 45. Celltrion Corporate Summary
Table 46. Celltrion HER2 Antibodies Product Offerings
Table 47. Celltrion HER2 Antibodies Revenue (US$, Mn), (2017-2022)
Table 48. Biocon Corporate Summary
Table 49. Biocon HER2 Antibodies Product Offerings
Table 50. Biocon HER2 Antibodies Revenue (US$, Mn), (2017-2022)
Table 51. Novus Biologicals Corporate Summary
Table 52. Novus Biologicals HER2 Antibodies Product Offerings
Table 53. Novus Biologicals HER2 Antibodies Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. HER2 Antibodies Segment by Type in 2021
Figure 2. HER2 Antibodies Segment by Application in 2021
Figure 3. Global HER2 Antibodies Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global HER2 Antibodies Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global HER2 Antibodies Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by HER2 Antibodies Revenue in 2021
Figure 8. By Type - Global HER2 Antibodies Revenue Market Share, 2017-2028
Figure 9. By Application - Global HER2 Antibodies Revenue Market Share, 2017-2028
Figure 10. By Region - Global HER2 Antibodies Revenue Market Share, 2017-2028
Figure 11. By Country - North America HER2 Antibodies Revenue Market Share, 2017-2028
Figure 12. US HER2 Antibodies Revenue, (US$, Mn), 2017-2028
Figure 13. Canada HER2 Antibodies Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico HER2 Antibodies Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe HER2 Antibodies Revenue Market Share, 2017-2028
Figure 16. Germany HER2 Antibodies Revenue, (US$, Mn), 2017-2028
Figure 17. France HER2 Antibodies Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. HER2 Antibodies Revenue, (US$, Mn), 2017-2028
Figure 19. Italy HER2 Antibodies Revenue, (US$, Mn), 2017-2028
Figure 20. Russia HER2 Antibodies Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries HER2 Antibodies Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux HER2 Antibodies Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia HER2 Antibodies Revenue Market Share, 2017-2028
Figure 24. China HER2 Antibodies Revenue, (US$, Mn), 2017-2028
Figure 25. Japan HER2 Antibodies Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea HER2 Antibodies Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia HER2 Antibodies Revenue, (US$, Mn), 2017-2028
Figure 28. India HER2 Antibodies Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America HER2 Antibodies Revenue Market Share, 2017-2028
Figure 30. Brazil HER2 Antibodies Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina HER2 Antibodies Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa HER2 Antibodies Revenue Market Share, 2017-2028
Figure 33. Turkey HER2 Antibodies Revenue, (US$, Mn), 2017-2028
Figure 34. Israel HER2 Antibodies Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia HER2 Antibodies Revenue, (US$, Mn), 2017-2028
Figure 36. UAE HER2 Antibodies Revenue, (US$, Mn), 2017-2028
Figure 37. Novartis HER2 Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer HER2 Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Roche HER2 Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Abnova HER2 Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. InvivoGen HER2 Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Celltrion HER2 Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Biocon HER2 Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Novus Biologicals HER2 Antibodies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)